Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...

How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

WASHINGTON (AP) — Head Start programs that serve more than 58,000 of the nation’s neediest preschoolers are facing a cutoff of federal funding at the end of the month because of the government ...

I'm curious to see some of the receivers who will be used in Fantasy lineups in Week 7, especially in deeper formats. While CeeDee Lamb (ankle) and Mike Evans (hamstring) might return to action after ...

Palmer Luckey’s ambitious crypto-friendly digital banking startup Erebor has received conditional approval from regulators to start operations, federal officials announced Wednesday. As The Post was ...

You have lineup questions, we have lineup answers -- at least we hope so. Start 'Em, Sit 'Em is here to help fantasy managers make difficult roster decisions. And you know what is a good move?